Authors
Loading...
Ramipril was associated with fewer CV events in high-risk patients; leaves open optimal use in contemporary practice.
Key points are not available for this paper at this time.
Richard A. Wiklund (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: